A New Target for Amyloid Beta Toxicity Validated by Standard and High-Throughput Electrophysiology
Open Access
- 8 January 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (1) , e8643
Abstract
Soluble oligomers of amyloid beta (Aβ) are considered to be one of the major contributing factors to the development of Alzheimer's disease. Most therapeutic development studies have focused on toxicity directly at the synapse. Patch clamp studies detailed here have demonstrated that soluble Aβ can also cause functional toxicity, namely it inhibits spontaneous firing of hippocampal neurons without significant cell death at low concentrations. This toxicity will eventually lead to the loss of the synapse as well, but may precede this loss by a considerable amount of time. In a key technological advance we have reproduced these results utilizing a fast and simple method based on extracellular electrophysiological recording of the temporal electrical activity of cultured hippocampal neurons using multielectrode arrays (MEAs) at low concentrations of Aβ (1–42). We have also shown that this functional deficit can be reversed through use of curcumin, an inhibitor of Aβ oligomerization, using both analysis methods. The MEA recording method utilized here is non-invasive, thus long term chronic measurements are possible and it does not require precise positioning of electrodes, thus it is ideal for functional screens. Even more significantly, we believe we have now identified a new target for drug development for AD based on functional toxicity of hippocampal neurons that could treat neurodegenerative diseases prior to the development of mild cognitive impairment.Keywords
This publication has 44 references indexed in Scilit:
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Axon & dendrite degeneration: Its mechanisms and protective experimental paradigmsNeurochemistry International, 2007
- Functional screening of traditional antidepressants with primary cortical neuronal networks grown on multielectrode neurochipsEuropean Journal of Neuroscience, 2006
- Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyondNature Reviews Drug Discovery, 2006
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in VivoJournal of Biological Chemistry, 2005
- Micro-Electrode Arrays in Cardiac Safety PharmacologyDrug Safety, 2004
- Aβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targetsNeurochemistry International, 2002
- Impairment of hippocampal long-term potentiation by Alzheimer amyloid ?-peptidesJournal of Neuroscience Research, 2000
- Mechanisms of Neuronal Degeneration in Alzheimer's DiseaseNeuron, 1996
- The use of neuronal networks on multielectrode arrays as biosensorsBiosensors and Bioelectronics, 1995